InsidersTradesSigma
Browse the full record of transactions filed by Tango Therapeutics, Inc.. Director active across 1 companies, notably Blueprint Medicines Corp. In total, 2 disclosures have been published. The latest transaction was filed on 8 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations